BV-NSCLC-001: Phase III started

Bioven began an open-label, international Phase III trial to evaluate BV-NSCLC-001 plus cyclophosphamide and best supportive care in about 438 patients with inoperable, stage IIIb/IV NSCLC. Bioven has...